SCHEMBL26348556

SCHEMBL26348556

Cc1cc(N)nc(N2CCC(NCc3ccccc3)CC2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 6/20 0.55
ACHE P22303 4/20 0.51
BACE1 P56817 4/20 0.51
EBP Q15125 1/20 0.51
DHCR7 Q9UBM7 1/20 0.51
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 2/20 0.49
KMT2A Q03164 2/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GRIN2B Q13224 2/20 0.48
GRIN2D O15399 1/20 0.48
GRIN3B O60391 1/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2A Q12879 1/20 0.48
GRIN2C Q14957 1/20 0.48
GRIN3A Q8TCU5 1/20 0.48
BCHE P06276 3/20 0.48
CARM1 Q86X55 1/20 0.46
PRMT6 Q96LA8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26346543 0.86 HRH4 (0.47) HRH4ACHEBACE1GRIN2BGRIN2D
SCHEMBL26346156 0.83 MEN1 (0.58) HRH4ACHEBACE1MEN1ALDH1A1
SCHEMBL26348679 0.81 HRH4 (0.50) HRH4ACHEBACE1EBPDHCR7
SCHEMBL26348587 0.81 ACHE (0.56) ACHEBACE1EBPDHCR7MEN1
SCHEMBL26348201 0.79 HRH4 (0.55) HRH4ACHEBACE1MEN1KMT2A
SCHEMBL26348162 0.79 MEN1 (0.58) HRH4ACHEBACE1EBPDHCR7
SCHEMBL26348272 0.76 HRH4 (0.52) HRH4ACHEBACE1GRIN2BBCHE
SCHEMBL20692326 0.76 HRH4 (0.56) HRH4ACHEBACE1MEN1ALDH1A1
SCHEMBL26348238 0.73 AKT1 (0.52) HRH4ACHEBACE1EBPDHCR7
SCHEMBL7841536 0.72 ACHE (0.66) ACHEBACE1MEN1KMT2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303512-A1 MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303512-A1 MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF MYB, MYBBP1A, MYCBP HRH4 4801/4885ACHE 4510/4885BACE1 4775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.